Deltex Medical Group plc
DTXMFOTCHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$180577488
P/E Ratio—
52W High$0.09524
52W Low$0.0013
Deltex Medical Group plc (DTXMF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DTXMF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.06M | $1.78M | $2.48M | $2.26M | $2.40M |
| Cost of Revenue | $0.66M | $0.65M | $0.64M | $0.68M | $0.76M |
| Gross Profit | $1.40M | $1.13M | $1.84M | $1.57M | $1.64M |
| Gross Margin %(computed) | 68.00% | 63.34% | 74.09% | 69.72% | 68.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.29M | $0.22M | $0.23M | $0.21M | $0.25M |
| G&A Expenses | $1.09M | $1.08M | $1.56M | $1.58M | $1.47M |
| Total Operating Expenses | $2.98M | $2.18M | $2.82M | $2.44M | $2.21M |
| Operating Income | ($1.59M) | ($1.05M) | ($0.95M) | ($0.81M) | ($0.62M) |
| Operating Margin %(computed) | -77.14% | -59.23% | -38.15% | -35.64% | -25.94% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.23M | $0.20M | $0.17M | $0.17M |
| Income Before Tax | ($1.80M) | ($1.28M) | ($1.15M) | ($0.98M) | ($0.79M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.00M) | ($0.01M) | ($0.01M) |
| Net Income | ($1.80M) | ($1.28M) | ($1.15M) | ($0.97M) | ($0.79M) |
| Net Margin %(computed) | -87.40% | -72.18% | -46.13% | -42.76% | -32.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 1895.57M | 1181.57M | 685.49M | 580.71M | 526.45M |
| EBITDA | ($0.81M) | ($0.92M) | ($0.82M) | ($0.69M) | ($0.48M) |
| EBITDA Margin %(computed) | -39.25% | -51.75% | -33.00% | -30.59% | -20.02% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · GBP · M
Explore more Deltex Medical Group plc data
About Deltex Medical Group plc (DTXMF) Income Statement
Deltex Medical Group plc (DTXMF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, DTXMF reported revenue of $0.00B, gross profit of $0.00B (gross margin 68.00%), and net income of ($0.00B) — a net profit margin of -87.40%.
Frequently asked questions
DTXMF · 4 questionsDeltex Medical Group plc (DTXMF) reported revenue of $0.00B for 2024, up 15.8% year-over-year.
DTXMF revenueDTXMF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09